Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
“The probability that LDL will be retained within the arterial intima leading to the development and growth of atherosclerotic plaque increases with increasing concentration of circulating LDL particles.(6) Because retention of LDL particles is a probabilistic event, one would expect, therefore, that people with simila…”
BackgroundSelf-citationPoirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Mechanisms of plaque formation and rupture
Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
“apoB100-binding domain of arterial wall proteoglycans greatly reduces atherogenesis.(49,50) Thus, the atherogenicity of LDL is linked to the abil-”
BackgroundSelf-citationTabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341
Vascular smooth muscle cells in atherosclerosis
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0227-9 · Cited by 1,099
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
“Although this review only summarizes the role of ECs in LDL infiltration, it is important to note that other factors, such as the glycocalyx [82], pericytes [83], the subendothelial extracellular matrix [84,85], and the role of shear stress [32], should be considered.”
BackgroundINFLAMMATION AND ATHEROSCLEROSIS
Hansson, G. K., Robertson, A.-K. L., & Söderberg-Nauclér, C. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,046
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
Self-citationThe Pathology of Neoatherosclerosis in Human Coronary Implants
Nakazawa, G., Otsuka, F., Nakano, M., Vorpahl, M., Yazdani, S. K., Ladich, E., Kolodgie, F. D., Finn, A. V., & Virmani, R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.011 · Cited by 934
“Duration with any neoatherosclerosis, days 2,160 (1,800–2,880) 420 ( Incidence of any neoatherosclerosis 2 yrs 0/88 (0) 51/1 2 yrs, 6 yrs 17/76 (22) 13/ 6 yrs 14/33 (42) All 31/197 (16) 64/2 Incidence of foamy macrophage clusters 2 yrs 0/88 (0) 25/1 2 yrs, 6 yrs 2/76 (3) 6/ 6 yrs 3/33 (9) All 5/197 (3) 31/2 Incidence…”
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
“Both apoproteins can bind effectively to proteoglycans, the former via a newly identified binding segment of apo B 48 masked in apo B 100 [96] and the latter via a different domain [97].”
BackgroundVascular Adhesion Molecules in Atherosclerosis
Galkina, E., & Ley, K. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.149179 · Cited by 803
Atherothrombosis and High-Risk Plaque
Fuster, V., Moreno, P. R., Fayad, Z. A., Corti, R., & Badimon, J. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.074 · Cited by 738
The macrophage foam cell as a target for therapeutic intervention
Li, A. C., & Glass, C. K. (2002) · Nature Medicine · doi:10.1038/nm1102-1235 · Cited by 700
The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles
Lacolley, P., Regnault, V., Nicoletti, A., Li, Z., & Michel, J.-B. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs135 · Cited by 701
“Intimal sulphate-rich proteoglycans are able to bind apoB100 by ionic interaction with basic amino acids, and therefore to initiate fatty streaks.(101) In contrast to fatty streaks, the fibrocellular”
BackgroundAtherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
Steinberg, D. (2002) · Nature Medicine · doi:10.1038/nm1102-1211 · Cited by 679
Innate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Kadl, A., Meher, A. K., Sharma, P. R., Lee, M. Y., Doran, A. C., Johnstone, S. R., Elliott, M. R., Gruber, F., Han, J., Chen, W., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.215715 · Cited by 573
Borén, J., & Williams, K. J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000330 · Cited by 524
“Such interventions include mutagenesis of the proteoglycan/GAGbinding domain of apoB100, thereby slowing LDL retention and atherogenesis [36], manipulations of arterial matrix to alter its affinity for apoB [31,37–39,40 && ,41 & ], and knockouts of arterial-wall enzymes specifically implicated in apoB-lipoprotein rete…”
BackgroundSelf-citationVascular endothelium – Gatekeeper of vessel health
Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518
“Conversely, at regions of pathological low shear stress, increased endothelial permeability results in enhanced infiltration of LDL and its local accumulation, which is a critical initial event in the development of atherosclerosis [23,24].”
BackgroundWilliams, K. J., & Tabas, I. (2006) · Circulation · doi:10.1161/circulationaha.105.606962 · Cited by 486
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Moore, K. J., Kunjathoor, V. V., Koehn, S. L., Manning, J. J., Tseng, A. A., Silver, J. M., McKee, M., & Freeman, M. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24061 · Cited by 378
“As outlined in the original response-to-retention hypothesis formulated by Williams and Tabas (10, 11), serum lipoproteins accumulate in the arterial intima where a variety of modifications, including but not limited to oxidation, can alter their structure and enhance their uptake by recruited macrophages.”
BackgroundMonocyte recruitment and foam cell formation in atherosclerosis
Bobryshev, Y. V. (2006) · Micron · doi:10.1016/j.micron.2005.10.007 · Cited by 374
Endothelial permeability, LDL deposition, and cardiovascular risk factors—a review
Mundi, S., Massaro, M., Scoditti, E., Carluccio, M. A., van Hinsbergh, V. W. M., Iruela-Arispe, M. L., & De Caterina, R. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx226 · Cited by 367
Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican
Wight, T. N., & Merrilees, M. J. (2004) · Circulation Research · doi:10.1161/01.res.0000126921.29919.51 · Cited by 362
OLOFSSON, S. ‐., & BORÈN, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 330
Self-citationInsulin Resistance and Atherosclerosis
Nigro, J., Osman, N., Dart, A. M., & Little, P. J. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0007 · Cited by 314
“The importance of this hypothesis was strongly supported by the work of Jan Boren and colleagues (36), who showed that mice expressing genetically modified ApoB that had defective binding of lowdensity lipoprotein (LDL) to proteoglycans developed atherosclerosis at a rate that was appreciably less than those mice expr…”
BackgroundPaulson, K. E., Zhu, S.-N., Chen, M., Nurmohamed, S., Jongstra-Bilen, J., & Cybulsky, M. I. (2010) · Circulation Research · doi:10.1161/circresaha.109.210781 · Cited by 317
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315
Self-citationThe Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
Maiolino, G., Rossitto, G., Caielli, P., Bisogni, V., Rossi, G. P., & Calò, L. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/714653 · Cited by 314
Retinoid X receptors: X-ploring their (patho)physiological functions
Szanto, A., Narkar, V, Shen, Q., Uray, I. P., Davies, P. J. A., & Nagy, L. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401533 · Cited by 302
Nakashima, Y., Wight, T. N., & Sueishi, K. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn099 · Cited by 299
“Lipoprotein particles extracted from grossly normal human aortic intima show the same size and lipid composition as those of plasma low-density lipoprotein (LDL).40 Smith and Slater41 found a high percentage of unesterified cholesterol in the deep layers of the amorphous lipid pool in fibrous plaques and concluded tha…”
BackgroundInfluentialPathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)
O’Brien, K. D. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000227513.13697.ac · Cited by 295
Adaptive immunity and atherosclerosis
Andersson, J., Libby, P., & Hansson, G. K. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.07.002 · Cited by 293
“VCAM1 expression rises at sites of low shear stress and/or as a response to bioactive lipids such as oxidized LDL that have been trapped within the arterial wall or of locally-acting cytokines [11,12].”
BackgroundMacrophage Activation in Atherosclerosis: Pathogenesis and Pharmacology of Plaque Rupture
Boyle, J. (2005) · Current Vascular Pharmacology · doi:10.2174/1570161052773861 · Cited by 293
“It is postulated that matrix-bound sPLA2 may modify subendothelial LDL to an atherogenic form [53].”
BackgroundCurcio, C. A., Johnson, M., Huang, J.-D., & Rudolf, M. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.001 · Cited by 286
“, 1990; Guyton and Klemp, 1989), and the abatement of atherosclerosis by reduced apoB binding to intimal proteoglycans (Skålen et al., 2002).”
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., De Leon, J., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 270
“This binding of apoB100 to proteoglycans in the arterial wall is particularly significant as it is considered to be the primary mechanism for the retention of LDL in the subendothelium [72].”
BackgroundLC3-Associated Phagocytosis and Inflammation
Heckmann, B. L., Boada-Romero, E., Cunha, L. D., Magne, J., & Green, D. R. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.08.012 · Cited by 276
“During acute or chronic hyperlipidemia, cholesterol transported on low-density lipoproteins (LDL) infiltrate the arterial wall, are trapped in the intimal extracellular matrix, and become more susceptible to diverse modifications such as oxidation and proteolysis [131].”
Malek, G., Li, C.-M., Guidry, C., Medeiros, N. E., & Curcio, C. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63836-9 · Cited by 270
“Reduced apo B binding to intimal proteoglycans markedly attenuates atherosclerosis in mice.(26) Apo B is a large and intensively studied protein with globular and -helical amphipathic domains and -sheets.”
BackgroundAdaptive Response of T and B Cells in Atherosclerosis
Ketelhuth, D. F. J., & Hansson, G. K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306427 · Cited by 270
Obesity and cardiovascular disease
Poirier, P., & Eckel, R. H. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0049-8 · Cited by 260
“Atherosclerosis begins in childhood with deposits of cholesterol in macrophages and smooth muscle cells located in the intima of large muscular arteries to form fatty streaks [38, 39 ].”
Backgroundon behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM), Bucerius, J., Hyafil, F., Verberne, H. J., Slart, R. H. J. A., Lindner, O., Sciagra, R., Agostini, D., Übleis, C., Gimelli, A., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3259-3 · Cited by 257
“It is characterized by accumulation of lipids, inflammatory cells and connective tissue within the arterial wall leading to the formation of atherosclerotic plaques [4–6].”
BackgroundRanneh, Y., Ali, F., Akim, A. M., Hamid, H. A., Khazaai, H., & Fadel, A. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0285-9 · Cited by 250
“This latter can negatively charge sulfate group that bind to the positive charge of apo B-100 of LDL [93].”
BackgroundInfluentialDeterminants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
Leibundgut, G., Scipione, C., Yin, H., Schneider, M., Boffa, M. B., Green, S., Yang, X., Dennis, E., Witztum, J. L., Koschinsky, M. L., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040733 · Cited by 243
Coronary heart disease risk: Low-density lipoprotein and beyond
Shaya, G. E., Leucker, T. M., Jones, S. R., Martin, S. S., & Toth, P. P. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.04.002 · Cited by 236
Karlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. (2005) · PROTEOMICS · doi:10.1002/pmic.200401010 · Cited by 241
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239
“They accumulate in proportion to the increase in plasma triglyceride (7, 10, 15) and are believed to be able to contribute to the deposition of cholesterol in atherosclerotic lesions (15, 44) as well as promote inflammatory processes (16).”
BackgroundInhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
Hermansson, A., Ketelhuth, D. F. J., Strodthoff, D., Wurm, M., Hansson, E. M., Nicoletti, A., Paulsson-Berne, G., & Hansson, G. K. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092243 · Cited by 240
“To evaluate the role of TRBV31+ T cells in disease development, we used same strain crossed with the Ldlr/ (C57BL/6,129-Apobtm2SgyLdlrtm1Her (Skålén et al., 2002; provided by J. Borén, Göteborg University, Göteborg, Sweden) as they develop large atherosclerotic lesions, even on a normal chow diet,…”
MethodInflammatory mechanisms in atherosclerosis
HANSSON, G. K. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03416.x · Cited by 234
Endometriosis and Risk of Coronary Heart Disease
Mu, F., Rich-Edwards, J., Rimm, E. B., Spiegelman, D., & Missmer, S. A. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002224 · Cited by 235
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18) In contrast, high-density lipoprotein is antiatherogenic, removing cholesterol from cells in the arterial intima.”
Biglycan: A Multivalent Proteoglycan Providing Structure and Signals
Nastase, M. V., Young, M. F., & Schaefer, L. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412456380 · Cited by 238
Perivascular adipose tissue (PVAT) in atherosclerosis: a double-edged sword
Qi, X.-Y., Qu, S.-L., Xiong, W.-H., Rom, O., Chang, L., & Jiang, Z.-S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0777-x · Cited by 226
Crooke, R. M., Graham, M. J., Lemonidis, K. M., Whipple, C. P., Koo, S., & Perera, R. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400492-jlr200 · Cited by 225
“LDL has been causally implicated in atherogenesis, and elevated levels of plasma LDL cholesterol (LDL-C) are a major risk factor for cardiovascular disease (1, 4, 5).”
BackgroundCardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout Mice
Park, T.-S., Panek, R. L., Mueller, S. B., Hanselman, J. C., Rosebury, W. S., Robertson, A. W., Kindt, E. K., Homan, R., Karathanasis, S. K., & Rekhter, M. D. (2004) · Circulation · doi:10.1161/01.cir.0000148370.60535.22 · Cited by 223
Nagy, L., Szanto, A., Szatmari, I., & Széles, L. (2012) · Physiological Reviews · doi:10.1152/physrev.00004.2011 · Cited by 216
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
Michelsen, K. S., Doherty, T. M., Shah, P. K., & Arditi, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5901 · Cited by 212
“subendothelial retention (35) and creates an inflammatory ni-”
BackgroundNon-coding RNAs in cardiovascular cell biology and atherosclerosis
Fasolo, F., Di Gregoli, K., Maegdefessel, L., & Johnson, J. L. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz203 · Cited by 201
Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 201
Do the Apoe −/− and Ldlr −/– Mice Yield the Same Insight on Atherogenesis?
Getz, G. S., & Reardon, C. A. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306874 · Cited by 198
“In the Ldlr mice, the LDL predominantly associates with heparin sulfate proteoglycans via interaction with apoB100 residues 3359–3369.(17,18) This sequence is absent in apoB48, the predominant apoB species in the Apoe mice.”
Carr, S. S., Hooper, A. J., Sullivan, D. R., & Burnett, J. R. (2019) · Pathology · doi:10.1016/j.pathol.2018.11.006 · Cited by 193
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Borén, J., Packard, C. J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00474 · Cited by 196
“This is mediated by ionic interactions between positively charged domains in apoB100 (74), and negatively charged artery wall proteoglycans (75).”
BackgroundSelf-citationHermansson, A., Johansson, D. K., Ketelhuth, D. F. J., Andersson, J., Zhou, X., & Hansson, G. K. (2011) · Circulation · doi:10.1161/circulationaha.110.973222 · Cited by 189
The LDL cumulative exposure hypothesis: evidence and practical applications
Ference, B. A., Braunwald, E., & Catapano, A. L. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01039-5 · Cited by 176
“The trapping of LDL and other APOB-containing lipoproteins within the artery wall and the subsequent presentation of their cholesterol content to macrophages lead to a cascade of inflammatory events that is necessary for both the initiation and progression of atherosclerotic plaque formation 29–33 .”
Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance
Messner, B., & Bernhard, D. (2010) · BioMetals · doi:10.1007/s10534-010-9314-4 · Cited by 190
New insights on oxidative stress in the artery wall
STOCKER, R., & KEANEY, J. F. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01370.x · Cited by 188
PCSK9 and inflammation: a review of experimental and clinical evidence
Momtazi-Borojeni, A. A., Sabouri-Rad, S., Gotto, A. M., Pirro, M., Banach, M., Awan, Z., Barreto, G. E., & Sahebkar, A. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz022 · Cited by 188
Gonçalves, I., Edsfeldt, A., Ko, N. Y., Grufman, H., Berg, K., Björkbacka, H., Nitulescu, M., Persson, A., Nilsson, M., Prehn, C., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.249854 · Cited by 189
“There is strong evidence that this inflammation is induced by the retention and oxidation of low-density lipoprotein (LDL) in the subendothelial space.(1,2) Oxidized LDL is cytotoxic and may induce inflammation by causing arterial cell injury and by recruiting oxidized LDL-specific proinflammatory T cells to the arter…”
BackgroundInnate and adaptive immunity in atherosclerosis
Packard, R. R. S., Lichtman, A. H., & Libby, P. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0153-8 · Cited by 190
“The precursor lesion of atherosclerotic plaques, fatty streaks, have focal increases in the content of lipoproteins within regions of the intima where they associate with constituents of the extracellular matrix such as proteoglycans, slowing their egress [13].”
Rapid regression of atherosclerosis: insights from the clinical and experimental literature
Williams, K. J., Feig, J. E., & Fisher, E. A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1086 · Cited by 189
“The key initiating event in atherosclerosis is the retention, or trapping, of cholesterol-rich lipoproteins within the arterial wall”
BackgroundThe arterial microenvironment: the where and why of atherosclerosis
Yurdagul, A., Finney, A. C., Woolard, M. D., & Orr, A. W. (2016) · Biochemical Journal · doi:10.1042/bj20150844 · Cited by 185
“Proteoglycans, which change in abundance and type during atherosclerosis, directly bind LDL and mice expressing an LDL defective in proteoglycan-binding develop significantly less atherosclerosis [28, 157].”
BackgroundDuez, H., Chao, Y.-S., Hernandez, M., Torpier, G., Poulain, P., Mundt, S., Mallat, Z., Teissier, E., Burton, C. A., Tedgui, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206966200 · Cited by 186
Molecular determinants of endothelial transcytosis and their role in endothelial permeability
Predescu, S. A., Predescu, D. N., & Malik, A. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2006 · Cited by 188
“Since caveolin-1 and caveolae function in transcytosis of LDL cholesterol particles from the blood to the subendothelial space, they may play an important role in the development of atherosclerosis (49, 199, 215).”
Postprandial hypertriglyceridemia as a coronary risk factor
Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182
Self-citationConnexins in Vascular Physiology and Pathology
Brisset, A. C., Isakson, B. E., & Kwak, B. R. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2115 · Cited by 178
“Accumulation and oxidative modification of LDLs is a key component to the development and progression of atherosclerosis (5, 68, 112).”
Vancraeynest, D., Pasquet, A., Roelants, V., Gerber, B. L., & Vanoverschelde, J.-L. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.018 · Cited by 176
The Biological Role of Inflammation in Atherosclerosis
Wong, B. W., Meredith, A., Lin, D., & McManus, B. M. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.023 · Cited by 168
Bonaterra, G. A., Zügel, S., Thogersen, J., Walter, S. A., Haberkorn, U., Strelau, J., & Kinscherf, R. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002550 · Cited by 169
“Studies in animals and humans have shown that hypercholesterolemia causes infiltration and retention of LDL in the arterial intima and initiates an inflammatory response in the artery wall.(21,22) After monocytes have attached and roll on the endothelium, they transmigrate into the subendothelial space, differentiate…”
BackgroundGlycation of LDL by Methylglyoxal Increases Arterial Atherogenicity
Rabbani, N., Godfrey, L., Xue, M., Shaheen, F., Geoffrion, M., Milne, R., & Thornalley, P. J. (2011) · Diabetes · doi:10.2337/db11-0085 · Cited by 166
“PG binding has been implicated in subendothelial retention of LDL in animal models of atherogenicity (37).”
BackgroundGM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions
Zhu, S.-N., Chen, M., Jongstra-Bilen, J., & Cybulsky, M. I. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090866 · Cited by 166
“…10 2141-2149 www.jem.org/cgi/doi/10.1084/jem.20090866 2141 BRIEF DEFINITIVE REPORT In atherosclerosis, serum lipoproteins, particularly low density lipoprotein (LDL), accumulate in the arterial intima through binding to matrix proteoglycans (Skålén et al., 2002) and undergo oxidative modification.”
BackgroundInfluentialGenome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells
Kraehling, J. R., Chidlow, J. H., Rajagopal, C., Sugiyama, M. G., Fowler, J. W., Lee, M. Y., Zhang, X., Ramírez, C. M., Park, E. J., Tao, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms13516 · Cited by 165
“The rationale for identifying new pathways for LDL transit is predicated on the observations that (1) the uptake, transport and retention of sub-endothelial LDL particles can occur in an LDLR independent manner and contribute to the initiation of atherosclerosis1,2; (2) hypercholesterolemic levels of LDL will downregu…”
BackgroundLewis, K. E., Kirk, E. A., McDonald, T. O., Wang, S., Wight, T. N., O’Brien, K. D., & Chait, A. (2004) · Circulation · doi:10.1161/01.cir.0000136819.93989.e1 · Cited by 163
Kang, G. S., Gillespie, P. A., Gunnison, A., Moreira, A. L., Tchou-Wong, K.-M., & Chen, L.-C. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002508 · Cited by 160
“Lipid is one of the most studied and most important stimuli initiating atherogenesis (Mehra et al. 2005), and extra cellular accumulation of lipids occurs early in response to increased plasma lipoprotein levels in animals (Skalen et al. 2002).”
BackgroundMolecular processes that handle — and mishandle — dietary lipids
Williams, K. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35206 · Cited by 160
A role for proteoglycans in vascular disease
Wight, T. N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.019 · Cited by 160
“Transgenic mice overexpressing a defective PG-binding apoprotein, when fed a high-fat diet, failed to develop atherosclerosis after 20 weeks, even though serum cholesterols were significantly elevated [91].”
BackgroundDevlin, C. M., Leventhal, A. R., Kuriakose, G., Schuchman, E. H., Williams, K. J., & Tabas, I. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.173344 · Cited by 160
Oxidized phospholipids in cardiovascular disease
Tsimikas, S., & Witztum, J. L. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00937-4 · Cited by 173
“Indeed, it is difficult to physically or chemically extract apo(a) from human atherosclerotic specimens 22 , whereas apoB-100 is more loosely trapped in the extracellular matrix and can be more easily mobilized 23 .”
Morita, S.-Y. (2016) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00716 · Cited by 155
Barreto, J., Karathanasis, S. K., Remaley, A. T., & Sposito, A. C. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315421 · Cited by 164
Caveolae and transcytosis in endothelial cells: role in atherosclerosis
Frank, P. G., Pavlides, S., & Lisanti, M. P. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0659-8 · Cited by 162
“In the arterial intima, LDL may become trapped in the extracellular matrix where they may be modified (Hajjar and Haberland 1997; Skalen et al. 2002).”
Background
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.